Skip to main content
. 2021 Mar 31;7:GO.20.00430. doi: 10.1200/GO.20.00430

FIG 2.

FIG 2

The availability of various chemotherapeutic agents in the participating hospitals. GC-SF, granulocyte colony-stimulating factor; MEK, mitogen-activated protein kinase kinase.